cholesterol_med dep_maoi_med
Name
decongestants_med
Label
Decongestant: Self-reported use
Description

Self-reported drugs at PSG visit, open text then grouped according to effect

Domain
takingornot
  • 0: Not taking
  • 1: Taking
Type
choices
Decongestant: Self-reported use vs Study visit number
Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 Incident Outcomes Tracking
Total 1,123 758 566 121 2 -
Not taking 1,071 733 539 120 2 -
Taking 52 25 27 1 - -
Decongestant: Self-reported use vs Sex of the participant
Visit 1
Male Female Total
Total 608 515 1,123
Not taking 583 488 1,071
Taking 25 27 52
Decongestant: Self-reported use vs Sex of the participant
Visit 2
Male Female Total
Total 406 352 758
Not taking 398 335 733
Taking 8 17 25
Decongestant: Self-reported use vs Sex of the participant
Visit 3
Male Female Total
Total 304 262 566
Not taking 293 246 539
Taking 11 16 27
Decongestant: Self-reported use vs Sex of the participant
Visit 4
Male Female Total
Total 67 54 121
Not taking 67 53 120
Taking - 1 1
Decongestant: Self-reported use vs Sex of the participant
Visit 5
Male Female Total
Total - 2 2
Not taking - 2 2
Taking - - -
Decongestant: Self-reported use vs Race of the participant
Visit 1
Asian Black Hispanic Native American White Total
Total 12 23 13 10 1,065 1,123
Not taking 12 23 12 10 1,014 1,071
Taking - - 1 - 51 52
Decongestant: Self-reported use vs Race of the participant
Visit 2
Asian Black Hispanic Native American White Total
Total 4 8 6 6 734 758
Not taking 4 8 6 5 710 733
Taking - - - 1 24 25
Decongestant: Self-reported use vs Race of the participant
Visit 3
Asian Black Hispanic Native American White Total
Total 4 4 5 4 549 566
Not taking 4 4 5 4 522 539
Taking - - - - 27 27
Decongestant: Self-reported use vs Race of the participant
Visit 4
Asian Black Hispanic Native American White Total
Total 3 1 2 2 113 121
Not taking 3 1 2 2 112 120
Taking - - - - 1 1
Decongestant: Self-reported use vs Race of the participant
Visit 5
Asian Black Hispanic Native American White Total
Total - - - - 2 2
Not taking - - - - 2 2
Taking - - - - - -